STOCKHOLM, March 29 (Xinhua) -- A new COVID-19 prophylactic from AstraZeneca has been authorized for use in Sweden, the country's Medical Products Agency confirmed to Xinhua on Tuesday.
Evusheld has been licensed recently for prescription to individuals who, due to underlying medical conditions, have not developed satisfying protection against COVID-19 despite being vaccinated.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
